CO36 | Inhibitor titer at diagnosis and clinical course in acquired hemophilia A: a single-center experience

Background and Aims: Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder caused by neutralizing autoantibodies against factor VIII (FVIII). While the inhibitor titer is central to diagnosis and monitoring, its relationship with clinical severity and treatment outcomes remains controv...

Full description

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: PAGEPress Publications 2025-07-01
Series:Bleeding, Thrombosis and Vascular Biology
Subjects:
Online Access:https://www.btvb.org/btvb/article/view/243
Tags: Add Tag
No Tags, Be the first to tag this record!